Literature DB >> 12111458

The neuromelanin of human substantia nigra and its interaction with metals.

L Zecca1, D Tampellini, A Gatti, R Crippa, M Eisner, D Sulzer, S Ito, R Fariello, M Gallorini.   

Abstract

Neuromelanin (NM) is a peculiar biochemical component of several neurons in the Substantia Nigra (SN), the target area of the degenerative process in Parkinson Disease (PD). SN NM has peculiarities as to its composition and an impressive capacity of chelating metals, iron in particular, but not exclusively. Gaining insights into the structural and functional characteristics of NM should help understanding the reasons of selective vulnerability of nigral neurons in many parkinsonian conditions. From the present data a protective role of NM can be postulated until the buffering capability toward heavy metals are exhausted. The overloading of NM with iron and other metals in neurons may trigger inflammatory and degenerative processes aggravating the underlying pathological condition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12111458     DOI: 10.1007/s007020200055

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  29 in total

Review 1.  Neurotoxins as Preclinical Models for Parkinson's Disease.

Authors:  Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2018-01-08       Impact factor: 3.911

2.  Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

Authors:  F A Zucca; C Bellei; S Giannelli; M R Terreni; M Gallorini; E Rizzio; G Pezzoli; A Albertini; L Zecca
Journal:  J Neural Transm (Vienna)       Date:  2006-04-28       Impact factor: 3.575

Review 3.  Functional effects of neuromelanin and synthetic melanin in model systems.

Authors:  K L Double
Journal:  J Neural Transm (Vienna)       Date:  2006-05-05       Impact factor: 3.575

Review 4.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

Review 5.  Neurodegeneration and neuroprotection in Parkinson disease.

Authors:  Stanley Fahn; David Sulzer
Journal:  NeuroRx       Date:  2004-01

6.  A reappraisal of Fe(III) adsorption by melanin.

Authors:  Rhiannon Lee Schroeder; Jacobus Petrus Gerber
Journal:  J Neural Transm (Vienna)       Date:  2014-05-21       Impact factor: 3.575

Review 7.  Parkinson's disease and iron.

Authors:  Hideki Mochizuki; Chi-Jing Choong; Kousuke Baba
Journal:  J Neural Transm (Vienna)       Date:  2020-02-05       Impact factor: 3.575

8.  Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway.

Authors:  Julie Lotharius; Jeppe Falsig; Johan van Beek; Sarah Payne; Ralf Dringen; Patrik Brundin; Marcel Leist
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

9.  The expanding role and presence of neuromelanins in the human brain - why gray matter is gray.

Authors:  Vincent J Hearing
Journal:  Pigment Cell Melanoma Res       Date:  2008-12-19       Impact factor: 4.693

Review 10.  What are melanocytes really doing all day long...?

Authors:  P M Plonka; T Passeron; M Brenner; D J Tobin; S Shibahara; A Thomas; A Slominski; A L Kadekaro; D Hershkovitz; E Peters; J J Nordlund; Z Abdel-Malek; K Takeda; R Paus; J P Ortonne; V J Hearing; K U Schallreuter
Journal:  Exp Dermatol       Date:  2009-07-30       Impact factor: 3.960

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.